Skip to content

Effect of group biofeedback therapy on anxiety, depression and inflammatory immunity in lung cancer patients

Effect of group biofeedback therapy on anxiety, depression and inflammatory immunity in lung cancer patients

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055640
Enrollment
Unknown
Registered
2022-01-15
Start date
2022-02-10
Completion date
Unknown
Last updated
2023-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Experimental group:Group biofeedback therapy
Control group:Conventional nursing

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with histopathological diagnosis of lung cancer (diagnosed within 1 month, and have never received anti-tumor treatment); 2. Aged over 18 years and under 65 years; 3. Life expectancy of more than three months; 4. With the consent of the patient and his family, he can receive a full course of psychological treatment in our hospital; 5. SAS and (or) SDS score of 50 and above.

Exclusion criteria

Exclusion criteria: 1. Patients who are critically ill and cannot complete the survey; 2. People with a history of mental illness (such as schizophrenia, mania, anxiety, depression, phobia, etc.) or patients diagnosed with mental illness when the clinical trial was enrolled; 3. Patients with communication barriers and unable to answer normally due to confusion, aphasia, mental retardation and other reasons; 4. Patients who have received psychological treatment 3 months before enrollment; 5. Patients with brain metastases; 6. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Anxiety depression score;

Countries

China

Contacts

Public ContactZheng Rujun

West China Hospital of Sichuan University

zrj0000@126.com+86 18980606962

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026